Background
==========

Cardiovascular disease (CVD) is a leading cause of morbidity and mortality in the United States \[[@B1]\]. It is increasingly recognized that CVD is a life-course disease, with overt events being antedated by subclinical cardiovascular target organ damage \[[@B2],[@B3]\]. Current research indicates a fundamental role of left ventricular (LV) chamber size, wall thickness (LV remodeling) and mass (LVM) in the pathogenesis of high blood pressure \[[@B4],[@B5]\], and clinical CVD \[[@B6],[@B7]\], including stroke \[[@B8],[@B9]\] and heart failure \[[@B10]-[@B12]\]. On a parallel note, exercise treadmill stress testing (ETT) is used routinely to evaluate patients with chest pain suggestive of ischemic etiology and for identifying individuals at intermediate pre-test probability of CVD who are more likely to develop clinical events \[[@B13]\]. Likewise, endothelial dysfunction, as assessed via brachial artery (BA) flow-mediated dilation (FMD), has emerged as a fundamental component of atherosclerosis and a precursor of overt CVD \[[@B14]-[@B16]\]. Thus, traits obtained via echocardiography (Echo), testing for BA endothelial function and ETT can serve as intermediate phenotypes in the pathway from standard risk factor to overt CVD. Such intermediate phenotypes have been studied extensively to characterize their clinical and genetic correlates, have been reported to be heritable traits \[[@B14],[@B17]-[@B28]\], and have been linked to select genetic loci in several reports \[[@B29]-[@B31]\].

More recently, several investigators have proposed genome-wide association studies (GWAS) as a strategy to map causal genes with modest influences on traits associated with complex diseases such as CVD \[[@B32],[@B33]\]. The availability of 100K genotype data on a subset of related Framingham Heart Study participants \[[@B34]\] provides a unique opportunity to conduct both genome-wide association and linkage analyses to explore the genetic underpinnings of LV remodeling, endothelial function and exercise performance in a community-based sample.

Methods
=======

The design and selection criteria of the Original Framingham Study \[[@B35]\] and the Offspring Study \[[@B36]\] have been described elsewhere. As detailed in the Overview \[[@B37]\], 1345 participants (1087 Offspring and 258 Original Cohort) underwent genotyping using the Affymetrix GeneChip Human Mapping 100K single nucleotide polymorphism (SNP) set \[[@B34]\]. Participants were eligible for the present investigation if they had available genotypes and the echocardiographic, vascular and ETT traits of interest (as defined below). The Institutional Review Board at Boston University Medical Center approved the study and all participants gave written informed consent (including for genetic research).

Measurement of phenotypes
-------------------------

### Echocardiography

All attendees underwent routine transthoracic two-dimensionally-guided M-mode echocardiography at the second (1979--1982), fourth (1987--1990), fifth (1991--1995) and sixth (1996--1998) Offspring cohort examinations. Echocardiographic equipment for image acquisition varied across these examinations: at examination cycle 2, a Hoffrel 201 ultrasound receiver (and Aerotech transducer) was used; at examinations 4 and 5, a Hewlett Packard (model 77020AC) ultrasound machine was used; at examination 6 images were acquired using a Sonos 1000 Hewlett-Packard machine. At all four examinations, however, measurements of LV internal dimension in diastole (LVDD) and systole (LVDS), the thicknesses of the posterior wall (PW) and interventricular septum (IVS), and the diameters of the aortic root (all measured at end-diastole) and left atrium (LA) at end-systole were obtained by using a \'leading edge\' technique \[[@B38]\], averaging measurements in 3 cardiac cycles according to the American Society of Echocardiography guidelines. We calculated LV wall thickness (LVWT) as the sum of PW and IVS measurements. LV mass was calculated by using the formula 0.8\[1.04(LVDD+IVS+PW)^3^- (LVDD)^3^\] + 0.6 \[[@B39]\]. The reproducibility of Echo measurements was systematically assessed at the sixth examination \[[@B40]\].

### ETT measures

At the second Offspring examination (1978--1981), all attendees underwent submaximal exercise test according to the standard Bruce protocol for up to five incremental 3-minute stages. The test was terminated (without a cool down period) when participants reached their target heart rate (85% age-predicted peak heart rate). Blood pressure measurements and electrocardiograms were recorded during exercise at the midpoint of each 3-minute exercise stage, and for each minute for up to 4 minutes into the recovery period.

### BA endothelial function

As described previously \[[@B14]\], BA flow-mediated dilation (FMD; percent change in diameter from baseline; i.e. 100 \* \[hyperemic diameter at 1 minute - baseline diameter\]/baseline diameter) and mean hyperemic flow velocity (cm/sec) were determined during the seventh clinical examination cycle (1998--2001). A Toshiba SSH-140A ultrasound system with a 7.5 MHz linear array transducer and commercially available software (Brachial Analyzer version 3.2.3, Medical Imaging Applications) were used. Investigators, blinded to participant clinical and genetic data, determined brachial artery diameter at baseline and 1 minute after reactive hyperemia induced by 5-minute forearm cuff occlusion. The coefficient of variation for baseline and hyperemic diameters were 0.5% and 0.7%, respectively.

Doppler flow was assessed at baseline and during reactive hyperemia using a 3.75 MHz carrier frequency and with correction for the insonation angle \[[@B41]\]. Mean baseline and hyperemic flow velocities were analyzed from digitized audio data using semiautomated signal averaging (Cardiovascular Engineering, Waltham, MA). Baseline and deflation flow measurements were reproducible on repeated analysis of 30 subjects with correlations of \>0.98.

Genotyping methods
------------------

The Overview \[[@B37]\] details the genotyping performed with the Affymetrix 100K SNP GeneChip <http://gmed.bu.edu/about/genotyping.html>\[[@B34]\] and with the Marshfield STR marker set at the Mammalian Genotyping Service <http://research.marshfieldclinic.org/genetics>.

Statistical methods
-------------------

We generated normalized sex-specific residuals adjusting for the following covariates: for the echocardiographic phenotypes, age, sex, height, weight, smoking, systolic and diastolic blood pressure, hypertension treatment; for ETT measures, age, sex, body mass index, baseline heart rate, diabetes, smoking, ratio of total to high-density lipoprotein cholesterol, and treatment for hypertension (additional adjustments for select variables is detailed in Table [1](#T1){ref-type="table"}); for BA function, a set of 15 covariates previously reported \[[@B14]\] to be associated with endothelial function in our sample (see Table [1](#T1){ref-type="table"}). Covariates were from the same exam as the phenotype measures. Next, we used residuals for the phenotypes of interest to test for potential association with 100K SNPs using additive family-based association tests (FBAT) and linear regression models with general estimating equations (GEE; additive genetic models) to account for correlation among related individuals from nuclear families, as detailed in the Overview \[[@B37]\]. We chose 70,987 SNPS for association analysis that met the following criteria: autosomal SNPs with genotypic call rate ≥80%, minor allele frequency ≥10%, Hardy-Weinberg equilibrium test p ≥0.001, and ≥10 informative families for FBAT. The choice of an 80% genotyping call rate threshold may appear unusually liberal. We chose this threshold to be more inclusive in terms of associations reported. Also, the algorithm for the genotype calls was the Dynamic Modeling algorithm, which is less precise than other algorithms that have been introduced more recently. The association analyses were complemented by linkage analyses that used variance components methods and a subset of 100K markers and Marshfield STRs; the selection of markers and methods for calculating identity-by-descent are also described in the Overview \[[@B37]\].

###### 

Echocardiographic, exercise testing and brachial artery function traits analyzed in participants with 100K genotype data

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Trait**                                                        **Number of Traits\***   **Offspring Exam cycles**   **Adjustment**^†^      **Heritability**
  ---------------------------------------------------------------- ------------------------ --------------------------- ---------------------- ------------------
  **A. Echocardiographic Traits Averaged Across 4 Examinations**                                                                               

                                                                                                                                               

  LV mass (LVM)                                                    10                       2,4,5,6                     \- age- and sex-\      0.36
                                                                                                                        - multivariable-\*\*   

  LV diastolic dimension (LVDD)                                    10                       2,4,5,6                                            0.38

  LV systolic dimension (LVDS)                                     10                       2,4,5,6                                            0.30

  LV wall thickness (LVWT)                                         10                       2,4,5,6                                            0.41

  LV fractional shortening (LVFS)                                  10                       2,4,5,6                                            0.20

  Left atrial diameter (LAD)                                       10                       2,4,5,6                                            0.25

  Aortic root diameter (AOR)                                       10                       2,4,5,6                                            0.52

                                                                                                                                               

  **B. Exercise Treadmill Test (ETT) Traits**                                                                                                  

                                                                                                                                               

  Stage 2 Exercise systolic blood pressure (SBP)                   2                        2                           \- age- and sex-\      0.28
                                                                                                                        - multivariable-\*\*   

  Stage 2 Exercise diastolic blood pressure (DBP)                  2                        2                                                  0.22

  Stage 2 Exercise heart rate                                      2                        2                                                  0.25

  Post-exercise 3 minute recovery SBP                              2                        2                                                  0.20

  Post-exercise 3 minute recovery DBP                              2                        2                                                  0.16

  Post-exercise 3 minute recovery heart rate                       2                        2                                                  0.40

                                                                                                                                               

  **C. Brachial Artery (BA) Endothelial Function Traits**                                                                                      

                                                                                                                                               

  Baseline BA diameter                                             2                        7                           \- age- and sex-\      0.25
                                                                                                                        - multivariable-\*\*   

  Baseline BA flow velocity                                        2                        7                                                  0.32

  BA flow-mediated dilation (FMD) percent                          2                        7                                                  0.19

  BA hyperemic flow velocity                                       2                        7                                                  0.06
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------

BA = brachial artery. LV = left ventricular. SBP = systolic blood pressure. DBP = diastolic blood pressure.

\* For Echo traits, the phenotypes listed include those based on averaged values across 4 examinations. Overall, the number of Echo phenotypes includes individual traits at each exam (× 2 for two levels of adjustment in models) plus the averaged traits across 4 exams (× 2 for two levels of adjustment in models) listed above. For ETT and BA traits, the number of individual traits includes traits at single exams (× 2 for two levels of adjustment in models).

\*\*covariates in multivariable models include:

For Echo phenotypes: age, sex, height, weight, smoking, systolic blood pressure, diastolic blood pressure, hypertension treatment.

For ETT phenotypes: age, sex, BMI, diabetes, current smoking, baseline heart rate, hypertension treatment, total/HDL cholesterol. Additional adjustments were ETT phenotype-specific: Exercise SBP was also adjusted for systolic BP at rest; exercise DBP for diastolic BP at rest; exercise heart rate for heart rate at rest; Recovery SBP for systolic BP at rest, systolic BP during second stage of exercise, and peak systolic BP during exercise; Recovery DBP for diastolic BP at rest, diastolic BP during second stage of exercise, and peak diastolic BP during exercise; and recovery heart rate for heart rate at rest, during second stage of exercise, and peak heart rate during exercise.

For BA phenotypes: age, sex, mean arterial pressure, pulse pressure, heart rate, diabetes, body mass index, fasting blood glucose, prevalent cardiovascular disease, hormone replacement therapy use, walk test before and after BA test, Total/HDL cholesterol, smoking within 6 hrs of BA test, hypertension, lipid-lowering treatment use.

We used an unfiltered approach and report the top 25 SNPs associated with echocardiographic traits, ETT measures and BA phenotypes (15, 5 and 5 SNPs, respectively; relative proportions chosen empirically because of the larger number of echocardiographic traits analyzed) according to their degree of statistical significance (lowest p values) in GEE and FBAT models separately. For echocardiographic phenotypes, we analyzed the mean of values for traits averaged across the 4 examinations, as well as traits at individual examinations separately. In order to evaluate potential pleiotropic effects, we examined SNP associations across related sets of traits and listed the top 25 SNPs with the lowest geometric mean of p values for all echocardiographic traits (averaged across the four examinations), for all ETT measures and for all BA traits (15, 5 and 5 SNPs, respectively, for the 3 groups). Because we analyzed individual echocardiographic traits at each of the four examinations, we also listed the top SNP associations based on the geometric mean of p values for these individual echocardiographic traits across the four examinations. Thus, we use the term \'pleiotropic effects\' to refer to whether there were SNPs that were associated with multiple traits within the 3 subgroups. Additionally, we examined associations of SNPs in or within 200 Kb of the start or terminus of six selected genes (*ACE, AGT, AGTR1, ADRB1, VEGF, NOS3*) that have been previously reported to be associated with Echo, ETT and BA function phenotypes \[[@B30],[@B42]-[@B51]\]. We view these analyses as exploratory because the coverage of the Affymetrix 100K GeneChip for these genes was quite limited.

Results
=======

Table [1](#T1){ref-type="table"} lists the phenotypes analyzed from the three groups (Echo, ETT and BA endothelial function), the number of traits evaluated within each group, and the covariates included in regression models to create residuals. We observed moderate to high heritability of most of the traits evaluated (Table [1](#T1){ref-type="table"}; estimates are multivariable-adjusted, for covariates noted above under methods, and listed in table footnote). Heritability estimates were 52% for aortic root dimension, 36--40% for LV mass, internal dimensions and LVWT, and 25% for LA size. Estimates for ETT measures varied from 41% for post-exercise recovery heart rate, 28% for exercise systolic blood pressure, and 16--25% for other phenotypes. For BA function, baseline flow velocity and vessel diameter were most heritable (32 and 25%, respectively) and hyperemic flow the least (6%), with intermediate values for FMD (19%).

Results of all association analyses and detailed linkage results are web-posted at <http://ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?id=phs000007>, the database of genotype and phenotype public repository (dbGaP) at the National Center for Biotechnology Information. Overall, nine SNPs yielded a p value \<10^-5^in either GEE or FBAT models for Echo traits. Eleven SNPs were associated with ETT traits with a p value \<10^-5^, and one SNP yielded a p value below this threshold for BA function traits. A conservative Bonferroni correction for the number of statistical tests (0.05/1,000,000) yields an approximate threshold of genome-wide significance of 5\*10^-8^.

Table [2A](#T2){ref-type="table"} displays the 25 most significantly associated SNPs in GEE analyses (15 for echo phenotypes; 5 each for ETT and BA phenotypes; additive genetic models) sorted by p values along with the corresponding p value using FBAT. The top SNPs associated with averaged Echo traits included: rs1379659 and rs666088 (both in *SLIT2*) with LV diastolic dimension, rs1935881 (*FAM5C*) and rs10493389 (*PDE4B*) with LA diameter, and rs10504543 (*KCNB2*) with LV systolic dimension. The top SNPs associated with ETT traits included: rs6847149 (*NOLA1*) and rs2056387 (*RYR2*) with stage 2 exercise heart rate, and rs2553268 (*WRN*) with stage 2 exercise systolic blood pressure. The top 5 SNPs associated with BA traits included rs3814219 (*OBFC1*) and rs10515508 (*NRG2*) with BA baseline flow, and rs4148686 (*CFTR*) with FMD. Only one of these SNPs (*SLIT2*) had a p value \< 10^-3^in FBAT.

###### 

Top associations for Echo, ETT and BA function traits based on lowest p value for GEE test (2a), FBAT (2b), and Linkage (2c)\*

  **2A. Top Associations based on lowest GEE p values**                                                                                                                                                  
  --------------------------------------------------------------------------------------------- ---------------- ---------------- ----------------------- ----------------------- ---------------------- ---------------------------------
  **Trait**                                                                                     **SNP**          **Chromosome**   **Physical position**   **GEE p-value**         **FBAT p-value**       **In/near Gene (within 60 kb)**
                                                                                                                                                                                                         
  **I. Top 15 SNPs associated with Echocardiographic Traits (Averaged across exams)**                                                                                                                    
                                                                                                                                                                                                         
  LV diastolic dimension                                                                        rs1379659        4                20296952                **1.17\*10^-7^**        0.001                  *SLIT2*
  LV fractional shortening                                                                      rs366676         6                88774485                **2.44\*10^-6^**        0.059                  *SPACA1*
  LV diastolic dimension                                                                        rs666088         4                20171404                **5.10\*10**^-6^        0.008                  *SLIT2*
  LV systolic dimension                                                                         rs10504543       8                73941196                **5.18\*10**^-6^        0.247                  *KCNB2*
  Left atrial diameter                                                                          rs1935881        1                186798043               **5.56\*10**^-6^        0.003                  *FAM5C*
  LV mass                                                                                       rs10498091       2                221724949               **5.68\*10**^-6^        0.162                  
  Left atrial diameter                                                                          rs10493389       1                66022886                **6.56\*10**^-6^        0.119                  *PDE4B*
  LV diastolic dimension                                                                        rs4920799        5                84642284                **6.84\*10**^-6^        0.041                  
  LV wall thickness                                                                             rs10519181       15               76076030                **1.04\*10**^-5^        0.027                  *TBC1D2B*
  LV diastolic dimension                                                                        rs6104740        20               11284809                **1.15\*10**^-5^        0.021                  
  LV diastolic dimension                                                                        rs2900208        12               11769731                **1.20\*10**^-5^        0.021                  *ETV6*
  LV systolic dimension                                                                         rs3766377        1                157613632               **1.25\*10**^-5^        0.032                  *CD244*
  LV diastolic dimension                                                                        rs10511762       9                25621130                **1.29\*10**^-5^        0.002                  *TUSC1*
  LV mass                                                                                       rs4936770        11               122434085               **1.37\*10**^-5^        0.019                  *HSPA8*
  LV diastolic dimension                                                                        rs4485619        20               11251676                **1.57\*10**^-5^        0.043                  
                                                                                                                                                                                                         
  **II. Top 5 SNPs associated with ETT Traits**                                                                                                                                                          
                                                                                                                                                                                                         
  Stage 2 Exercise heart rate                                                                   rs6847149        4                111157701               **2.74\*10**^-6^        0.014                  *NOLA1*
  Stage 2 Exercise heart rate                                                                   rs2819770        1                234237045               **3.53\*10**^-6^        0.010                  *RYR2*
  Post-exercise 3 minute recovery SBP                                                           rs746463         11               109501154               **4.88\*10**^-6^        0.564                  
  Stage 2 Exercise heart rate                                                                   rs2056387        1                234250153               **5.17\*10**^-6^        0.002                  *RYR2*
  Stage 2 Exercise SBP                                                                          rs2553268        8                31055898                **6.32\*10**^-6^        0.001                  *WRN*
                                                                                                                                                                                                         
  **III. Top 5 SNPs associated with BA endothelial function Traits**                                                                                                                                     
                                                                                                                                                                                                         
  Baseline BA flow velocity                                                                     rs3814219        10               105637085               **9.48\*10**^-7^        0.325                  *OBFC1*
  BA FMD percent                                                                                rs4148686        7                116728468               **1.13\*10**^-5^        0.025                  *CFTR*
  Baseline BA flow velocity                                                                     rs1471639        14               33552277                **1.26\*10**^-5^        0.001                  
  Baseline BA diameter                                                                          rs1045182        6                116705168               **1.44\*10**^-5^        0.058                  *TSPYL1*
  Baseline BA flow velocity                                                                     rs10515508       5                139355254               **1.71\*10**^-5^        0.016                  *NRG2*
                                                                                                                                                                                                         
  **2B. Top associations based on lowest FBAT p value**                                                                                                                                                  
                                                                                                                                                                                                         
  **Trait**                                                                                     **SNP**          **Chromosome**   **Physical position**   **GEE p-value**         **FBAT p-value**       **In/near Gene (within 60 kb)**
                                                                                                                                                                                                         
  **I. Top 15 SNPs associated with Echocardiographic Traits (Averaged across exams)**                                                                                                                    
                                                                                                                                                                                                         
  LV systolic dimension                                                                         rs1392284        3                114584100               0.139                   **6.39\*10**^-6^       *WDR52*
  LV fractional shortening                                                                      rs10515040       17               48859319                0.211                   **1.29\*10**^-5^       
  LV fractional shortening                                                                      rs9312006        3                8234491                 0.002                   **1.64\*10**^-5^       
  LV systolic dimension                                                                         rs10504591       8                76199715                0.046                   **1.95\*10**^-5^       
  LV fractional shortening                                                                      rs448458         15               60591780                0.206                   **2.26\*10**^-5^       
  LV diastolic dimension                                                                        rs580859         13               68030441                0.046                   **2.68\*10**^-5^       
  LV systolic dimension                                                                         rs1959290        14               86208482                2.07\*10^-5^            **6.42\*10**^-5^       
  Aortic root diameter                                                                          rs2468680        8                140590402               0.690                   **6.12\*10**^-5^       
  LV systolic dimension                                                                         rs448458         15               60591780                0.019                   **5.60\*10**^-5^       
  LV systolic dimension                                                                         rs2918268        5                148586949               0.574                   **4.82\*10**^-5^       *ABLIM3*
  LV mass                                                                                       rs965036         6                20099022                0.033                   **3.69\*10**^-5^       
  Left atrial diameter                                                                          rs1701821        7                112544622               0.137                   **3.66\*10**^-5^       
  Aortic root diameter                                                                          rs7544568        1                38308301                0.194                   **3.21\*10**^-5^       
  LV fractional shortening                                                                      rs10504591       8                76199715                0.112                   **2.92\*10**^-5^       
  LV diastolic dimension                                                                        rs1488745        3                1976802                 0.141                   **2.72\*10**^-5^       
                                                                                                                                                                                                         
  **II. Top 5 SNPs associated with ETT Traits**                                                                                                                                                          
                                                                                                                                                                                                         
  Post-exercise 3 minute recovery SBP                                                           rs2016718        8                96813381                0.006                   **2.20\*10**^-7^       
  Post-exercise 3 minute recovery heart rate                                                    rs1029947        7                150713400               0.013                   **9.20\*10**^-7^       *PRKAG2*
  Post-exercise 3 minute recovery heart rate                                                    rs1029946        7                150713454               0.022                   **3.89\*10**^-6^       *PRKAG2*
  Stage 2 Exercise heart rate                                                                   rs1958055        14               33254537                0.040                   **8.55\*10**^-6^       *NPAS3*
  Post-exercise 3 minute recovery SBP                                                           rs7828552        8                71862761                0.057                   **9.34\*10**^-6^       *XRG9*
                                                                                                                                                                                                         
  **III. Top 5 SNPs associated with BA endothelial function Traits**                                                                                                                                     
                                                                                                                                                                                                         
  BA hyperemic flow velocity                                                                    rs1859634        7                100758808               0.030                   **1.21\*10**^-5^       *AK124120*
  BA FMD percent                                                                                rs1106494        14               62201734                0.003                   **1.61\*10**^-5^       *KCNH5*
  BA hyperemic flow velocity                                                                    rs2389866        4                120872866               0.423                   **2.12\*10**^-5^       *PDE5A*
  Baseline BA diameter                                                                          rs774227         9                91273496                0.002                   **2.34\*10**^-5^       *NFIL3*
  Baseline BA diameter                                                                          rs10502887       18               43433881                0.002                   **2.79\*10**^-5^       
                                                                                                                                                                                                         
  **2C. Magnitude and location of peak LOD scores ≥2.0 for Echo, ETT and BA function traits**                                                                                                            
                                                                                                                                                                                                         
  **Trait**                                                                                     **SNP or STR**   **Chromosome**   **Physical position**   **Maximum LOD score**   **LOD-1.5 interval**   **LOD+1.5 interval**
                                                                                                                                                                                                         
  **I. Echocardiographic Traits (Averaged across examinations)**                                                                                                                                         
                                                                                                                                                                                                         
  LV mass                                                                                       rs10515509       5                139270238               4.37                    133816612              150634674
  Aortic root diameter                                                                          rs10513442       3                154474088               4.22                    150552924              161813142
  LV wall thickness                                                                             rs3813713        10               51241137                3.16                    32818116               58684005
  LV wall thickness                                                                             rs10511550       9                10638555                3.11                    10220368               15384347
  LV fractional shortening                                                                      AFM254ve1        3                198506417               2.78                    195278503              199138789
  LV wall thickness                                                                             rs2438085        2                105339005               2.59                    103478258              106924695
  Left atrial diameter                                                                          rs7327514        13               78334100                2.55                    68655834               90511230
  LV wall thickness                                                                             rs1719           15               83149176                2.45                    64238853               86738287
  LV mass                                                                                       rs10489725       1                181172198               2.41                    176249023              201595809
  LV mass                                                                                       rs1989051        8                129363300               2.38                    127811630              133926399
  LV wall thickness                                                                             GATA164B08       3                8560016                 2.25                    2183832                20875136
                                                                                                                                                                                                         
  **II. ETT Traits**                                                                                                                                                                                     
                                                                                                                                                                                                         
  Stage 2 Exercise heart rate                                                                   rs190982         5                88259176                2.93                    71236666               96112374
  Stage 2 Exercise heart rate                                                                   GATA165C03       1                60383884                2.46                    43070922               67006164
  Stage 2 Exercise heart rate                                                                   rs7286558        22               20504737                2.43                    15786453               25685518
  Stage 2 Exercise heart rate                                                                   rs10483844       14               71902088                2.39                    53240301               74937294
                                                                                                                                                                                                         
  **III. BA Endothelial Function Traits**                                                                                                                                                                
                                                                                                                                                                                                         
  Baseline BA flow velocity                                                                     rs1425727        8                25642697                2.14                    19459783               32261074
  BA FMD percent                                                                                D21S11           21               19476134                2.13                    10000969               27037800
  Baseline BA flow velocity                                                                     rs3007456        9                42925816                2.12                    36878975               76736108

\*SNPs are ordered by GEE p values. dbSNP positions are from NCBI Build 35 (hg17).

Abbreviations as in Table 1. The number of informative families for FBAT analyses ranged from a minimum of 80 to a maximum of 210.

Table [2B](#T2){ref-type="table"} lists the top 25 SNPs associated with phenotypes in FBAT along with corresponding p values in GEE models. Only one of these SNPs (rs1959290 associated with LV systolic dimension) had a p value \< 10^-3^in GEE models. The top 5 SNPs associated with ETT traits included rs1029947 and rs1029946 (both in *PRKAG2*) with heart rate at 3 minutes of post-exercise recovery. The top 5 SNPs associated with BA traits included rs2389866 (*PDE5A*).

Table [2C](#T2){ref-type="table"} lists the magnitude and the location of loci with LOD scores that exceeded 2.0. The peak LOD scores were: for Echo traits, 4.38 (chromosome 5) for LV mass and 4.23 (chromosome 3) for aortic root size; for ETT traits, 2.93 (chromosome 5), 2.46 (chromosome 1), and 2.43 (chromosome 22) for heart rate during stage 2 of exercise; for BA traits, 2.14 (chromosome 8) for baseline flow velocity.

Table [3](#T3){ref-type="table"} evaluates the potential pleiotropic effect of SNPs by evaluating the geometric mean of p values for associations across averaged echo, and single-exam ETT and BA traits, and by relating them to the individual Echo traits across 4 examinations. SNPs associated with 4 genes (*SLIT2, WDR72, UBE2L3 and KCNB2*) were related to individual echo traits across examinations, as well as associated with the averaged Echo traits. Likewise, *RYR2*was associated with a low geometric p value when related to all ETT traits across the examination.

###### 

Top associations ordered by geometric mean of GEE p-values across traits (3 groups) and across examinations (echo traits)

  **Trait**                                                                                  **SNP**      **Chromosome**   **Physical position**   **GEE p-value**   **In/near Gene (within 60 kb)**
  ------------------------------------------------------------------------------------------ ------------ ---------------- ----------------------- ----------------- ---------------------------------
  **IA. Top 15 SNPs associated with Echocardiographic Traits across individual exams**                                                                               
                                                                                                                                                                     
  LV diastolic dimension                                                                     rs4920799    5                84642284                0.001             
  LV diastolic dimension                                                                     rs1379659    4                20296952                0.001             *SLIT2*
  Aortic root diameter                                                                       rs26438      5                165221499               0.001             
  LV mass                                                                                    rs473664     15               51598287                0.0016            *WDR72*
  Aortic root diameter                                                                       rs10488825   11               81688520                0.0017            
  LV mass                                                                                    rs10498091   2                221724949               0.0017            
  LV diastolic dimension                                                                     rs10514431   16               76498035                0.0018            *KIAA1576*
  LV diastolic dimension                                                                     rs10505599   8                133812159               0.0019            *FLJ33069*
  LV systolic dimension                                                                      rs10504543   8                73941196                0.0019            *KCNB2*
  LV diastolic dimension                                                                     rs2900208    12               11769731                0.0019            *ETV6*
  LV mass                                                                                    rs861857     22               20306894                0.0022            *UBE2L3*
  LV systolic dimension                                                                      rs10501940   11               99440078                0.0023            *CNTN5*
  LV systolic dimension                                                                      rs707025     2                155014031               0.0023            *GALNT13*
  Aortic root diameter                                                                       rs1395204    18               4477509                 0.0025            
  LV diastolic dimension                                                                     rs10513272   9                116143601               0.0026            *PAPPA*
                                                                                                                                                                     
  **IB. Top 15 SNPs associated with Averaged Echocardiographic Traits (across LV traits)**                                                                           
                                                                                                                                                                     
  Across LV phenotypes                                                                       rs1379659    4                20296952                0.0007            *SLIT2*
                                                                                             rs10498091   2                221724949               0.0009            
                                                                                             rs861857     22               20306894                0.001             *UBE2L3*
                                                                                             rs473664     15               51598287                0.0012            *WDR72*
                                                                                             rs3766377    1                157613632               0.0016            *CD244*
                                                                                             rs10504543   8                73941196                0.0017            *KCNB2*
                                                                                             rs10518462   4                126562521               0.0018            
                                                                                             rs1959289    14               86208319                0.0026            
                                                                                             rs667269     3                175822307               0.0027            
                                                                                             rs1959290    14               86208482                0.0027            
                                                                                             rs1959291    14               86208525                0.0027            
                                                                                             rs10485104   6                165966351               0.0030            *PDE10A*
                                                                                             rs10491574   9                116701992               0.0030            *ASTN2*
                                                                                             rs707025     2                155014031               0.0032            *GALNT13*
                                                                                             rs525960     1                149310939               0.0033            *LCE5A*
                                                                                                                                                                     
  **II. Top 5 SNPs associated with ETT Traits (across traits)**                                                                                                      
                                                                                                                                                                     
  Across phenotypes                                                                          rs1560916    17               28973892                0.0101            *ACCN1*
                                                                                             rs1432214    2                137712255               0.0106            
                                                                                             rs10512056   9                76835140                0.0112            *LOC442425*
                                                                                             rs2056387    1                234250153               0.0115            *RYR2*
                                                                                             rs6560812    10               2363105                 0.0132            
                                                                                                                                                                     
  **III. Top 5 SNPs associated with BA endothelial Traits (across traits)**                                                                                          
                                                                                                                                                                     
  Across phenotypes                                                                          rs2912991    7                52684247                0.0029            
                                                                                             rs10510677   3                36168070                0.007             
                                                                                             rs10493052   1                33614778                0.007             *ZNF31*
                                                                                             rs7155941    14               41681710                0.008             
                                                                                             rs1954627    14               41689011                0.009             

dbSNP positions are from NCBI Build 35 (hg17).

Abbreviations as in Table 1.

Table [4A--C](#T4){ref-type="table"} displays results of association of Echo, ETT and BA function traits with SNPs in proximity to 6 genes (within 200 Kb of the start or terminus) chosen from the published literature; as noted earlier, the Affymetrix 100K GeneChip does not cover SNPs within these genes adequately. We observed weak associations of several SNPs in proximity to the genes of interest and Echo, ETT and BA function traits, none of which had a p value \< 10^-3^). It is noteworthy, though, that several SNPs in proximity to *ADRB1, AGT*, and *AGTR1*were associated weakly (p value of 0.05 to 10^-3^) with several Echo, ETT and BA function phenotypes.

###### 

Associations of traits with SNPs in or near (up to 200 kb away) 6 well-replicated genes in the published literature with a p-value \< 0.05 in either FBAT or GEE.

  **4A. Associations of averaged echo traits**                                                                                                                                                                  
  ---------------------------------------------- ----------------------------------------------------------------------- ----------------------- -------------------------------------------- ----------------- ------------------
  **Candidate Gene**                             **FHS 100K SNP**                                                        **Physical Position**   **Trait**                                    **GEE p-value**   **FBAT p-value**
                                                                                                                                                                                                                
  ***ACE***                                      no SNP was associated with a p value \< 0.05 for any LV trait studies                                                                                          
                                                                                                                                                                                                                
  ***ADRB1***                                    rs10510001                                                              115962372               LV diastolic dimension                       0.004             0.0002
                                                 rs10510001                                                              115962372               LV systolic dimension                        0.001             0.001
                                                 rs10510000                                                              115961985               LV diastolic dimension                       0.052             0.001
                                                 rs10510000                                                              115961985               LV systolic dimension                        0.059             0.001
                                                 rs7902873                                                               115884949               LV diastolic dimension                       0.467             0.002
                                                 rs10509999                                                              115917269               LV diastolic dimension                       0.136             0.003
                                                 rs180940                                                                115712401               LV wall thickness                            0.003             0.072
                                                 rs180934                                                                115720720               LV wall thickness                            0.005             0.090
                                                 rs180935                                                                115720249               LV wall thickness                            0.005             0.160
                                                 rs998334                                                                115957002               LV diastolic dimension                       0.289             0.005
                                                 rs7902873                                                               115884949               LV systolic dimension                        0.249             0.006
                                                 rs10509999                                                              115917269               LV systolic dimension                        0.036             0.008
                                                 rs180935                                                                115720249               LV mass                                      0.011             0.409
                                                 rs180934                                                                115720720               LV mass                                      0.015             0.411
                                                 rs7902873                                                               115884949               LV mass                                      0.646             0.016
                                                 rs998334                                                                115957002               LV systolic dimension                        0.110             0.018
                                                 rs10510001                                                              115962372               LV fractional shortening                     0.021             0.056
                                                 rs10510000                                                              115961985               LV fractional shortening                     0.382             0.027
                                                 rs180940                                                                115712401               LV mass                                      0.029             0.303
                                                 rs10510001                                                              115962372               LV mass                                      0.393             0.040
                                                 rs6585258                                                               115739125               LV mass                                      0.047             0.481
                                                 rs10510000                                                              115961985               LV mass                                      0.335             0.048
  ***AGT***                                      rs10495300                                                              227188497               Left atrial diameter                         0.095             0.001
                                                 rs2478518                                                               227174605               LV fractional shortening                     0.028             0.238
                                                 rs1202585                                                               227309949               LV wall thickness                            0.030             0.028
                                                 rs2180478                                                               227295655               LV diastolic dimension                       0.800             0.030
                                                 rs758216                                                                227005969               Aortic root diameter                         0.031             0.341
                                                 rs1202524                                                               227257907               LV diastolic dimension                       0.323             0.037
                                                 rs2478518                                                               227174605               LV systolic dimension                        0.038             0.467
                                                 rs731824                                                                227329806               Left atrial diameter                         0.043             0.399
                                                 rs1202585                                                               227309949               LV mass                                      0.044             0.117
  ***AGTR1***                                    rs1059502                                                               150045008               Aortic root diameter                         0.598             0.005
                                                 rs1357424                                                               149801524               LV fractional shortening                     0.075             0.006
                                                 rs1357424                                                               149801524               LV systolic dimension                        0.241             0.030
                                                 rs1059502                                                               150045008               LV diastolic dimension                       0.142             0.030
                                                 rs2331406                                                               150048180               Aortic root diameter                         0.589             0.032
                                                 rs10513333                                                              149786557               Left atrial diameter                         0.437             0.039
  ***VEGF***                                     rs729761                                                                43912549                LV fractional shortening                     0.012             0.200
                                                 rs729761                                                                43912549                Left atrial diameter                         0.573             0.018
                                                 rs729761                                                                43912549                LV systolic dimension                        0.018             0.249
                                                 rs2396083                                                               43912786                LV fractional shortening                     0.026             0.250
                                                 rs2396083                                                               43912786                Left atrial diameter                         0.489             0.031
                                                 rs2396083                                                               43912786                LV systolic dimension                        0.040             0.224
                                                                                                                                                                                                                
  ***NOS3***                                     No SNP was associated with a p value \< 0.05 for any LV trait studied                                                                                          
                                                                                                                                                                                                                
  **4B. Associations of ETT traits**                                                                                                                                                                            
                                                                                                                                                                                                                
  **Candidate Gene**                             **FHS 100K SNP**                                                        **Physical Position**   **Trait**                                    **GEE p-value**   **FBAT p-value**
                                                                                                                                                                                                                
  ***ACE***                                      rs10491167                                                              58780430                Stage 2 Exercise systolic blood pressure     0.046             0.137
                                                 rs10491168                                                              58795195                Stage 2 Exercise systolic blood pressure     0.030             0.124
                                                 rs721575                                                                59136652                Post-exercise 3 minute recovery heart rate   0.024             0.025
  ***ADRB1***                                    rs2419857                                                               115607366               Stage 2 Exercise heart rate                  0.852             0.030
                                                 rs4345919                                                               115651155               Post-exercise 3 minute recovery heart rate   0.048             0.740
  ***AGT***                                      rs1752189                                                               227000046               Post-exercise 3 minute recovery SBP          0.145             0.021
                                                 rs758216                                                                227005969               Post-exercise 3 minute recovery SBP          0.184             0.050
                                                 rs10495298                                                              227120049               Stage 2 Exercise systolic blood pressure     0.288             0.050
                                                 rs2478516                                                               227175387               Stage 2 Exercise systolic blood pressure     0.021             0.486
  ***AGTR1***                                    rs275678                                                                149851039               Post-exercise 3 minute recovery SBP          0.216             0.049
                                                 rs427832                                                                149949061               Post-exercise 3 minute recovery SBP          0.014             0.171
                                                 rs1949350                                                               150089423               Stage 2 Exercise heart rate                  0.010             0.335
  ***VEGF***                                     rs729761                                                                43912549                Stage 2 Exercise heart rate                  0.041             0.035
  ***NOS3***                                     rs2303928                                                               150176978               Stage 2 Exercise heart rate                  0.012             0.056
                                                                                                                                                                                                                
  **4C. Associations of BA function traits**                                                                                                                                                                    
                                                                                                                                                                                                                
  **Candidate Gene**                             **FHS 100K SNP**                                                        **Physical Position**   **Trait**                                    **GEE p-value**   **FBAT p-value**
                                                                                                                                                                                                                
  ***ACE***                                      no SNP was associated with a p value \< 0.05                                                                                                                   
                                                                                                                                                                                                                
  ***ADRB1***                                    rs180940                                                                115712401               BA hyperemic flow velocity                   0.581             0.015
                                                 rs180935                                                                115720249               BA hyperemic flow velocity                   0.953             0.030
                                                 rs180934                                                                115720720               BA hyperemic flow velocity                   0.662             0.029
                                                 rs10509999                                                              115917269               BA hyperemic flow velocity                   0.001             0.137
                                                 rs10510000                                                              115961985               BA hyperemic flow velocity                   0.007             0.014
                                                 rs10510001                                                              115962372               BA hyperemic flow velocity                   0.017             0.239
  ***AGT***                                      rs758216                                                                227005969               Baseline BA flow velocity                    0.049             0.488
                                                 rs1202585                                                               227309949               Baseline BA diameter                         0.002             0.080
                                                 rs1202585                                                               227309949               BA hyperemic flow velocity                   0.049             0.080
  ***AGTR1***                                    rs1492090                                                               149884751               BA hyperemic flow velocity                   0.026             0.293
                                                 rs427832                                                                149949061               Baseline BA flow velocity                    0.509             0.043
  ***VEGF***                                     rs833048                                                                43762514                BA hyperemic flow velocity                   0.860             0.036
                                                 rs10498756                                                              44046909                BA hyperemic flow velocity                   0.312             0.008
  ***NOS3***                                     rs741067                                                                149938103               Baseline BA diameter                         0.043             0.024
                                                 rs1006581                                                               149949571               Baseline BA diameter                         0.009             0.097
                                                 rs2215564                                                               150001612               BA hyperemic flow velocity                   0.028             0.104

dbSNP positions are from NCBI Build 35 (hg17).

Discussion
==========

Principal findings
------------------

We report results of GWAS of Echo, ETT and BA function traits in a moderate-size community-based sample using several complementary analytical approaches. Our principal findings are five-fold. First, we observed modest to strong evidence of heritability for several Echo, ETT and BA function traits, underscoring the contribution of additive genetic effects to interindividual variation in these traits. Our heritability findings confirm prior reports for some of the traits \[[@B18],[@B20],[@B22],[@B23],[@B27],[@B28],[@B52]\], including from our group \[[@B14],[@B24]\]. Second, notwithstanding the modest-to-high heritability, none of the SNP-trait associations we observed achieved genome-wide significance (conservative Bonferroni correction p of 5\*10^-8^). Therefore, any associations presented should be viewed as hypothesis-generating, with need for replication in additional samples. Third, our investigation highlights some of the challenges inherent in the interpretation of GWAS results. We did not observe any overlap between the top SNPs noted in GEE-based versus FBAT-based analyses, in part due to the inherent differences in the two analytical methods (see Overview for details \[[@B37]\]). Fourth, notwithstanding the lack of genome-wide statistical significance, our data do suggest several interesting biological candidates among the SNPs most strongly associated with different traits in the various analytical approaches (see discussion below). Fifth, we were quite limited in our ability to replicate findings for genetic variants previously associated with the traits that we investigated because specific coverage of such genetic variation in these candidates was limited in the Affymetrix 100K GeneChip. Therefore, the lack of replication of SNPs in proximity to 6 genes previously reported to be associated with Echo, ETT and BA traits should be interpreted with great caution. It is interesting that several weak associations (p between 0.05 and 10^-3^) were observed between traits in the three groups and SNPs in proximity to selected candidate genes evaluated (*ADRB1*, *AGT*and *AGTR1*).

Potential biological candidates among observed associations
-----------------------------------------------------------

In our GWAS of Echo traits, a SNP in *SLIT2*was associated with Echo LV diastolic dimension in several analyses. *SLIT2*is an evolutionarily highly conserved gene that encodes a putative secreted protein, which contains conserved protein-protein interaction domains including leucine-rich repeats and epidermal growth factor-like motifs \[[@B53]\]. The gene has multiple effects but has been recently identified to have a novel role in vascular function by contributing to migratory mechanisms in vascular smooth muscle cells \[[@B54]\]. Likewise, the associations of LV mass with *HSPA8*, and of LA size with *PDE4B*are consistent with the key role of heat shock protein expression \[[@B55]\] and T-cell mediated immune responses \[[@B56]\], respectively, in myocardial hypertrophic responses to insults or hemodynamic overload.

Analyses of ETT traits provided some interesting results. The association of a SNP in *RYR2*with exercise heart rate responses in multiple analyses is quite consistent with the fundamental role of the ryanodine receptor on the sarcoplasmic reticulum in calcium trafficking during cardiac muscle excitation-contraction coupling \[[@B57]\]. Furthermore, *RYR2*has been implicated in exercise-induced polymorphic ventricular tachyarrhythmias \[[@B58]\]. Using FBAT, SNPs in *PRKAG2*were associated with heart rate during the recovery period post-exercise. Mutations in *PRKAG2*, an enzyme that modulates glucose uptake and glycolysis \[[@B59]\], are associated with glycogen-filled vacuoles in cardiomyocytes. The phenotypic manifestations include cardiac hypertrophy, ventricular pre-excitation and conduction system disturbances, encompassed together in the Wolff-Parkinson-White syndrome \[[@B60]\].

Genetic linkage analyses of ETT traits identified peaks on chromosomes 5 and 22 for exercise heart rate. The 1.5 LOD support intervals for these peaks included *MEF2C*and *MAPK1*, respectively. *MEF2C*is a critical regulator of cardiac morphogenesis \[[@B61]\]. Additionally, overexpression of *MEF2C*in experimental studies is associated with disturbances in extracellular matrix remodeling, ion handling, and metabolism of cardiomyocytes \[[@B62]\]. The peak on *MAPK1*is of interest because a recent investigations highlighted the role of MAPK signaling in mediating the responses of skeletal muscles to exercise training \[[@B63]\].

A SNP in *NRG2*was associated with BA flow velocity at rest, and also was in proximity to the top LOD peak for LV mass, raising the possibility of pleiotropic effects of this gene on ventricular and vascular remodeling and function. *NRG2*, which encodes neuregulin-2, is a member of the epidermal growth factor (EGF) family and binds to ErbB receptors. ErbB signaling has been implicated in angiogenesis and endothelial cell proliferation \[[@B64]\]. Of interest, a SNP in *CFTR*was associated with FMD. It is noteworthy that *CFTR*is expressed in vascular smooth muscle cells and activation of *CFTR*chloride channels regulates contraction and relaxation of smooth muscle cells; disruption of the *CFTR*gene prevents cAMP-dependent vasorelaxation in experimental studies \[[@B65]\]. *CFTR*is also expressed in endothelial cells where it functions as a cyclic nucleotide-regulated chloride channel \[[@B66]\]. Of interest, a SNP in *PDE5A*was associated with BA hyperemic flow velocity in FBAT analyses. Phosphodiesterase 5 (PDE5) hydrolyzes cyclic guanosine monophosphate (cGMP) and cyclic adenosine monophosphate (cAMP), is widely expressed in the vasculature, and is best known as the target of sildenafil, a drug used to treat erectile dysfunction \[[@B67]\]. PDE5 degrades cGMP in smooth muscle cells so as to maintain the contracted state of blood vessels \[[@B67]\]. *PDE5A*may also play a critical role in the growth promoting effects of Angiotensin II on vascular smooth muscle cells \[[@B68]\].

Strengths and limitations
-------------------------

The moderate-sized community-based sample, availability of longitudinal Echo measurements, routine ascertainment of standardized and reproducibly-measured traits, and evaluation of multiple complementary analytical methods including assessment of potential pleiotropic genetic effects strengthen our investigation. By web-posting unfiltered aggregate data we provide a resource for the scientific community to conduct in silico replication. Nonetheless, several limitations must be emphasized. As noted previously, the lack of genome-wide significance for any association observed given the extent of multiple statistical testing does not exclude a potential role of genetic influences on the traits studied. We had limited statistical power to detect modest genetic effects, given the sample size and the extent of multiple testing. As detailed in the Overview paper \[[@B37]\], for a conservative alpha level such as 10^-8^, we have more than 90% power to detect an association with a SNP explaining 4% or more total phenotypic variation when 80% or more individuals are phenotyped. We also had limited ability to replicate previously reported findings, in view of the partial coverage of genetic variation in select candidates with the Affymetrix 100K gene chip. Additionally, genetic variants may influence phenotypes in a context-specific manner \[[@B69]\], being modulated by environmental influences. For instance, the associations of *ACE*and *AGTR2*with LV mass were reported to vary according to dietary salt intake in one investigation \[[@B48]\]. We did not undertake an investigation of gene-environmental interactions in the present study. Likewise, some of the moderately strong associations may represent false-positive results, notwithstanding the evidence suggesting that some of the associated SNPs may be reasonable biological candidates. We averaged echocardiographic traits across multiple examinations, with a view to characterizing the phenotype better over a period of time using several observations. Such a strategy could limit regression dilution bias, if the examinations are repeated over a short period of time. In our study, however, these examinations spanned a time period of twenty years, and the examinations used different echocardiographic equipment that may introduce misclassification. Further, such averaging assumes that similar sets of genes and environmental factors influence traits over a wide age range. Such an assumption may not be true, i.e., age-dependent gene effects may be masked by averaging of observations across ages in participants. Lastly, our sample was white and of European descent. The generalizability of our findings to other ethnicities is unknown.

Conclusion
==========

In hypothesis-generating GWAS of Echo, ETT response and BA vascular function in a moderate size community-based sample, we identified several SNPs that are potential candidates for replication. Overall, our investigation provides a scientific framework for analyzing and interpreting GWAS of phenotypes fundamental to our understanding of cardiac and vascular remodeling and hemodynamic responses to exercise testing. We expect the Framingham 100K SNP data to serve as a valuable scientific resource by virtue of the web-posting of unfiltered aggregate data
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